Skip to main content
. 2019 Feb 1;58(10):1391–1397. doi: 10.2169/internalmedicine.0864-18

Table 1.

Baseline Clinical Characteristics of Cardiac Arrest Patients Treated with Extracorporeal Life Support.

Patients: n (%) Favorable neurological outcome
(n=20)
Unfavorable neurological outcome
(n=47)
p value
Age (years) 62.35±13.50 65.11±14.32 0.47
Male gender 14 (70.0) 36 (76.6) 0.56
Body mass index (kg/m2) 23.9±3.39 23.5±3.67 0.62
Cardiovascular risk factor
Hypertension 13 (65.0) 26 (55.3) 0.59
Smoker 12 (60.0) 23 (48.9) 0.44
Diabetes 7 (35.0) 17 (36.2) >0.99
Dyslipidemia 16 (80.0) 35 (74.5) 0.76
CKD (e-GFR<60) 4 (20.0) 16 (34.0) 0.38
Reason for CPR
Acute coronary syndrome 19 (95.0) 38 (80.9) 0.26
Left main trunk 3 (15.0) 6 (12.8) >0.99
Myocardial rupture 0 (0.0) 8 (17.0) 0.10
Non-ACS ventricular fibrillation 1 (5.0) 9 (19.1) 0.26
OHCA 3 (15.0) 13 (27.7) 0.36
Transport time (min) 21.3±9.61 27.6±16.46 0.54
IHCA 17 (85.0) 34 (72.3) 0.36
Initial rhythm at CA
Asystole 3 (15.0) 8 (17.0) >0.99
PEA 2 (10.0) 9 (19.1) 0.48
VT/VF 14 (70.0) 26 (55.3) 0.29
Not reported 1 (5.0) 4 (8.5) >0.99
Initial pH 7.25±0.24 7.20±0.20 0.43

Data are presented as percentages and absolute numbers or means±standard deviation, unless otherwise specified.

e-GFR: estimated glomerular filtration rate, CPR: cardiopulmonary resuscitation, CA: cardiac arrest, OHCA: out-of-hospital cardiac arrest, IHCA: in-hospital cardiac arrest, PEA: pulseless electrical activity, VT: ventricular tachycardia, VF: ventricular fibrillation